InvestorsHub Logo
icon url

dr_lowenstein

11/13/17 3:10 PM

#41808 RE: ash111 #41803

There s no credible pv calculation. This is driven by traders , gotta luv them
icon url

buckiii2

11/13/17 5:48 PM

#41848 RE: ash111 #41803

SAN DIEGO, Nov. 13, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into entered into a Warrant Exercise Agreement with certain holders of outstanding warrants to purchase up to an aggregate of 5,509,642 shares of the Company's common stock, at its stated exercise price of $1.69 per share. Although each holder agreed to exercise, from time-to-time and in accordance with the terms of the warrants, the holders exercised all of the warrants held by it for cash today.

As a result, the Company received gross proceeds of approximately $9.3 million from the exercise of the warrants. The Company expects to use the proceeds for working capital and general corporate purposes, including primarily for its PISCES/KEYNOTE-695 clinical trial and for other clinical and research and development activities.